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Helicobacter pylori
 
 (Hp) is a highly successful human
pathogen that has colonized the gastric mucosa of approxi-
mately half of the world’s population. Infection with this
gram-negative bacterium induces a state of chronic inflam-
mation that does not resolve the underlying infection and
often leads to gastric or duodenal ulcers or more rarely to
gastric adenocarcinoma or mucosa-associated lymphoid tis-
sue (MALT) lymphoma. A characteristic feature of Hp-
induced inflammation is the massive recruitment of phago-
cytes (particularly neutrophils) to the gastric mucosa, and it
is generally believed that the ensuing tissue damage is due
to the combined effects of bacterial factors and host inflam-
matory mediators. Multiple bacterial virulence factors are
known to modulate Hp-induced inflammation, including
LPS, PicB, urease, and the vacuolating cytotoxin VacA (1).
Of particular interest in this regard is a recently identified
virulence factor called Hp neutrophil-activating protein
(HP-NAP). HP-NAP is a 150-kD dodecameric iron-bind-
ing protein that promotes adhesion of PMNs to endothelial
cells (2, 3). In this issue, Satin et al. demonstrate that puri-
fied recombinant HP-NAP is a highly antigenic protein
that stimulates phagocyte chemotaxis, NADPH oxidase as-
sembly, and production of reactive oxygen species (ROS)
(4). Interestingly, all Hp strains examined thus far carry the
 
napA
 
 gene; however, protein expression is variable and the
mechanism by which 
 
napA
 
 expression is regulated is un-
known (2). That not all Hp produce HP-NAP is signifi-
cant, as Hp strains have generally been divided into two
groups (5). Type I strains are associated with phagocyte in-
filtration and tissue damage and are commonly found in
 
persons with ulcer disease. In contrast, type II strains in-
 
duce much less inflammation and are associated with asymp-
tomatic infection. Moreover, our laboratory has recently
demonstrated that type I Hp resist phagocytic killing and
persist inside macrophages, whereas type II Hp do not (6).
Collectively, the available data suggest that Hp has evolved
a unique ability to stimulate certain phagocyte functions
while inhibiting others. Here, the features of Hp virulence
factors that individually and collectively contribute to the
ability of Hp to activate phagocytes yet avoid clearance by
the host immune response are discussed.
 
Phagocyte Recruitment in Response to Hp
 
In response to chemotactic agents, mononuclear phago-
cytes and PMNs upregulate surface adhesion receptors and
are recruited from the bloodstream to sites of infection.
During the course of a normal infection, PMNs are re-
cruited early, macrophages are more abundant at later
times, and phagocyte numbers decline upon elimination of
the invading microbe. The fact that neutrophils consis-
tently outnumber macrophages in the Hp-infected stomach
suggests that Hp induces a state of “chronic acute inflam-
mation.” Moreover, the available data suggest that phago-
cyte recruitment is directly modulated by HP-NAP and
 
factors secreted by the Type IV organelle (see below)
encoded by the 
 
cag
 
 pathogenicity island (
 
cag
 
 PAI) (1, 2, 4,
7, 8).
HP-NAP was originally identified as a component of Hp
outer membranes that stimulated PMN attachment to en-
dothelial cells (2). Satin et al. now demonstrate that purified
HP-NAP induces adhesion and chemotaxis of both mono-
nuclear phagocytes and PMNs by upregulating adhesion
 
receptors of the 
 
b
 
2 integrin family (4). The biochemical
data indicate that HP-NAP oligomers are found both in
the cytosol and on the bacterial surface; however, HP-
 
NAP lacks NH
 
2
 
- or COOH-terminal signals that would
confer export via the general 
 
sec
 
-dependent pathway or an
ATP-binding cassette transporter (Type II and Type I se-
cretion, respectively) (9). Consequently, it is not known
how HP-NAP reaches the outer membrane. Significantly,
Hp urease, another oligomeric virulence factor located in
the cytosol and on the bacterial surface, is thought to be
adsorbed onto the bacterial surface after “altruistic lysis” of
neighboring organisms (10). Moreover, surface urease is es-
sential for colonization because it generates ammonia to
buffer Hp as it passes through the highly acidic gastric lu-
men (10). Although altruistic lysis appears to be a some-
what arbitrary mechanism for targeting essential proteins to
the outer membrane, it is tempting to speculate that the
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unique surface properties of Hp support binding and reten-
tion of released HP-NAP and urease, and that this is im-
portant for bacterial persistence and ulcer formation. Al-
though mutants lacking HP-NAP have not yet been
characterized, the potency of this protein suggests that it is
a key player in mediating phagocyte recruitment during
Hp infection. In this regard, it will be of interest to deter-
mine whether HP-NAP is chemotactic for murine phago-
cytes, since PMN recruitment to the stomach is much less
pronounced in mouse models of Hp infection (11).
One distinguishing feature of type I Hp is the presence
of the 
 
cag
 
 PAI that encodes a Type IV secretion system (1,
8). Like Type III secretion systems, Type IV organelles are
found in virulent strains of some gram-negative bacteria,
and these large complexes of cytosolic, inner membrane,
and outer membrane proteins function as contact-depen-
dent molecular syringes to transport proteins directly into
host cells. Tight binding of type I Hp to the epithelium in-
duces synthesis and secretion of the neutrophil chemotactic
agent IL-8 via a nuclear factor (NF)-
 
k
 
B–dependent mecha-
nism, and Hp strains with mutations in PAI genes such as
 
picB/cagE
 
 are impaired in their ability to induce inflamma-
tion (12). Thus, it is likely that contact-dependent secretion
of one or more factors transported by the Type IV appara-
tus directly promotes PMN activation and migration to the
infected stomach.
At least two scenarios can be envisioned to explain the
dramatic difference in the ability of type I and type II Hp
to stimulate phagocyte migration to the gastric mucosa. In
one scenario, HP-NAP is responsible for the basal phago-
cyte recruitment to the gastric mucosa observed with all
strains of Hp, whereas signals provided by the Type IV se-
cretion apparatus recruit additional PMNs after coloniza-
tion by type I organisms. In a second scenario, HP-NAP
and the 
 
cag
 
 PAI may be coordinately expressed by type I
Hp to maximize phagocyte influx, whereas other factors
common to all Hp (such as LPS and urease) may regulate
phagocyte recruitment induced by type II organisms. Addi-
tional scenarios that allow for different levels of HP-NAP
expression are also possible.
 
Phagocyte Activation
 
Activated phagocytes exhibit an increased capacity to in-
gest and kill microorganisms. In part, phagocyte activation
stimulates assembly of the NADPH oxidase complex and
the respiratory burst. One key feature of the NADPH oxi-
dase is that the enzyme is unassembled and inactive in rest-
ing cells. Upon stimulation, the cytosolic components
p47
 
phox
 
, p67
 
phox
 
, p40
 
phox
 
, and rac2 translocate to the mem-
brane and bind cytochrome b558 (gp91
 
phox
 
/p22
 
phox
 
). Oxi-
dase activation is triggered by receptor–ligand interactions,
and the nature of the receptor engaged determines the site
of oxidant production (13). Specifically, soluble stimuli
such as FMLP and PMA promote oxidase assembly at the
plasma membrane and rapid release of superoxide into the
extracellular milieu. In contrast, phagocytic particles engag-
ing Fc
 
g
 
 receptors (FcRs) stimulate oxidase assembly on
forming phagosomes, and the subsequent concentration of
superoxide and hydrogen peroxide inside the phagocytic
vacuole maximizes toxicity to the ingested microbe and
minimizes damage to host tissues.
A key feature of some but not all strains of Hp is their
ability to bind to and activate PMNs and stimulate rapid
and robust production of ROS comparable to that induced
by PMA (14, 15). Although the site of NADPH oxidase as-
sembly was not determined in these studies, the speed and
magnitude of the response suggest that the oxidase was tar-
geted to the plasma membrane rather than the phagosome.
Consistent with this hypothesis, a growing body of evi-
dence suggests that type I Hp delay their entry into phago-
cytes (see below), and this delay may be essential for Hp to
target NADPH oxidase subunits to the cell surface. In the
current work, Satin et al. (4) clearly show that purified HP-
NAP is sufficient to induce oxidase assembly at the plasma
membrane and a strong respiratory burst in both mono-
cytes and PMNs. Interestingly, surface urease also plays a
key role in modulating the respiratory burst; and type I Hp
with surface urease bind PMNs and induce a strong respira-
tory burst by a mechanism that is independent of ammonia
production, whereas isogenic 
 
ureB
 
 mutants do not (16).
Collectively, the data suggest that coordinate adsorption of
HP-NAP and urease on the surface of type I Hp is essential
for these organisms to induce NADPH oxidase assembly at
the plasma membrane, extracellular release of ROS, and
ultimately ulcer formation. Although host tissue is dam-
aged, Hp is protected from the toxic effects of ROS by su-
peroxide dismutase and catalase (1).
In contrast, other strains of Hp bind poorly to PMNs
and do not stimulate production of ROS (14, 15). Binding
and phagocytosis of these less virulent organisms are en-
hanced after exposure to serum opsonins. However, op-
sonization is not sufficient to induce robust release of ROS
from PMNs, and these strains induce a weak and delayed
respiratory burst that likely reflects oxidase assembly on the
phagosome membrane (14, 15). Significantly, type II Hp
bind poorly to PMNs in the absence of opsonins (6), but
whether these less stimulatory strains are exclusively type II
Hp remains to be determined.
Although the combined effects of the 
 
cag
 
 PAI, urease,
and HP-NAP may suggest that Hp infection induces global
phagocyte activation, the effects of Hp LPS (endotoxin) ar-
gue against this hypothesis. In contrast to LPS derived from
 
Escherichia coli
 
 or 
 
Salmonella
 
, Hp LPS is at least 1,000-fold
less potent (17). Therefore, macrophage activation and
production of cytokines such as IL-1, IL-6, and TNF-
 
a
 
 are
limited during Hp infection (17). This may be explained in
part by the unusual structure of Hp LPS and its impaired
ability to bind LPS binding protein and CD14 (18). Conse-
quently, we would argue that Hp uses its virulence factors
to specifically stimulate the respiratory burst at a site of in-
fection where levels of phagocyte-activating cytokines are
otherwise limiting.
 
Modulation of Phagocytosis and the Intraphagosome Environment
 
The goal of phagocytes is to ingest and kill invading mi-
crobes, and killing usually occurs as a result of the com- 
1453
 
Allen
 
bined effects of ROS, phagosome acidification, and lysoso-
mal proteases. Phagocytosis is triggered when specific
receptors on the phagocyte bind ligands on the microbe
surface. Importantly, the receptors engaged during phago-
cytosis and subsequent signaling events modulate induction
of the respiratory burst, phagosome–lysosome fusion, and
consequently, the fate of the ingested microorganism. One
hallmark of intracellular pathogens is their ability to control
their fate inside phagocytes. On the other hand, the ability
of extracellular pathogens to modify the intraphagosomal
environment is less clear. Therefore, it is significant that at
least some strains of Hp resist phagocytic killing by both
macrophages and PMNs (6, 15, 19). Moreover, we hy-
pothesize that avoidance of phagocytic killing is intimately
linked to the ability of Hp to delay their entry into phago-
cytes and that this altered rate of uptake is also essential for
NAP-induced activation of plasma membrane NADPH
oxidase.
Although the receptor(s) that mediate ingestion of Hp
have not yet been identified, data from several laboratories
suggest that proteins on the surface of some strains of Hp
allow these organisms to regulate their uptake into phago-
cytes. First, as noted above, individual strains of Hp differ
in their ability to bind to PMNs although the reasons for
these differences have not been defined (6, 20). Second,
tight binding of Hp to PMNs correlates with abundant sur-
face urease, retarded phagocytosis, and strong respiratory
burst (16). Third, urease prevents deposition of serum op-
 
sonins onto Hp, thereby precluding rapid ingestion after
engagement of FcRs and CR3 (21). Fourth, opsonins re-
duce the amount of ROS produced by activating strains of
Hp (14, 15). Fifth, unopsonized type I and type II Hp bind
to macrophages; however, type I organisms exhibit delayed
phagocytosis that is sensitive to chloramphenicol, whereas
type II Hp are rapidly ingested (6). Sixth, delayed phagocy-
tosis is linked to intracellular survival, since type I Hp per-
sist inside macrophages within a novel vacuole called a
megasome, whereas rapidly ingested type II strains do not (6).
It is unlikely that NAP-mediated diversion of the NADPH
oxidase away from the phagosome is required for intra-
phagosomal survival of Hp; however, we believe that de-
layed ingestion of Hp is essential for both NAP-mediated
signaling and subsequent modification of the phagosome.
Consequently, ROS-induced tissue damage and persis-
tence of Hp are inherently linked, and both may be essen-
tial for Hp pathogenesis.
 
Conclusions
 
Hp is a highly successful human pathogen that persists in
the gastric mucosa. In this niche, bacteria usually thrive for
many years in spite of the host immune response. A grow-
ing body of evidence suggests that Hp
 
 
 
utilizes a broad array
of virulence factors to modulate its interactions with both
epithelial cells and phagocytes. Of particular interest in this
regard is the ability of type I Hp to both modulate its entry
into phagocytes and at the same time induce extensive tis-
Figure 1. Modulation of Hp–phagocyte interactions by HP-NAP, urease, and other virulence factors. (A) Type I/HP-NAP1/surface urease1 organ-
isms. Surface urease (blue dimers) prevents opsonization with C3 and antibodies (red circles and Ys), thereby preventing phagocytosis via FcRs (white
rectangles) and CR3 (gray dimers). An unidentified protein (green squares) allows Hp to bind tightly to the phagocyte via an unidentified receptor (light
purple squares). Signaling from this receptor induces phagocytosis after a delay of several minutes. Meanwhile, HP-NAP (pink hexagons), and perhaps
free NAP released after bacterial lysis, engage a G protein–coupled receptor (yellow circles) triggering translocation of p47/p67/p47phox (dark pink circles)
to the plasma membrane by a Src and phosphatidylinositol 3-kinase–dependent mechanism (reference 4). Ammonia generated by urease and superoxide
generated by the assembled NADPH oxidase (dark pink) damage host tissue. After ingestion and phagosome–phagosome fusion, Hp persist inside mega-
somes that resist fusion with lysosomes (reference 6). Mb., membrane. (B) Type II/HP-NAP2/surface urease2 organisms. In the absence of surface urease
and NAP, Hp is rapidly phagocytosed after opsonization with C3 and IgG, and does not stimulate oxidase assembly at the plasma membrane. Activation
of protein kinase Ca (PKCa) downstream of FcRs and CR3 stimulates NADPH oxidase assembly on the phagosome and subsequent phagosome–lyso-
some fusion (references 22, 23). Megasomes do not form, and Hp is killed and digested in phagolysosomes. cyto., cytoplasm. 
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sue damage by specifically activating the NADPH oxidase.
Although all of the players have not yet been identified, the
available data clearly indicate a key role for HP-NAP, ure-
ase, and other factors associated with type I organisms in
Hp-induced tissue damage and persistence. A possible
model that integrates the effects of these virulence factors is
shown in Fig. 1.
 
Submitted: 29 February 2000
Accepted: 20 March 2000
 
References
 
1. Covacci, A., J.L. Telford, G. Del Giudice, J. Parsonnet, and
R. Rappuoli. 1999. 
 
Helicobacter pylori
 
 virulence and genetic
geography. 
 
Science.
 
 284:1328–1333.
2. Evans, D.J., Jr., D.G. Evans, T. Takemura, H. Nakano, H.C.
Lambert, D.Y. Graham, D.N. Granger, and P.R. Kvietys.
1995. Characterization of a 
 
Helicobacter pylori
 
 neutrophil-acti-
vating protein. 
 
Infect. Immun.
 
 63:2213–2220.
3. Tonello, F., W.G. Dundon, B. Satin, M. Molinari, G.
Togon, G. Grandi, G. Del Giudice, R. Rappuoli, and C.
Montecucco. 1999. The 
 
Helicobacter pylori
 
 neutrophil-activat-
ing protein is an iron-binding protein with dodecameric
structure. 
 
Mol. Microbiol.
 
 34:238–246.
4. Satin, B., G. Del Giudice, V. Della Bianca, S. Dusi, C.
Laudanna, F. Tonello, D. Kelleher, R. Rappuoli, C. Mon-
tecucco, and F. Rossi. 2000. The neutrophil-activating pro-
tein (HP-NAP) of 
 
Helicobacter pylori
 
 is a protective antigen
and a major virulence factor. 
 
J. Exp. Med.
 
 191:1467–1476.
5. Xiang, Z., S. Censini, P.F. Bayeli, J.L. Telford, N. Figura, R.
Rappuoli, and A. Covacci. 1995. Analysis of expression of
CagA and VacA virulence factors in 43 strains of 
 
Helicobacter
pylori 
 
reveals that clinical isolates can be divided into two ma-
jor types and that CagA is not necessary for expression of the
vacuolating cytotoxin. 
 
Infect. Immun.
 
 63:94–98.
6. Allen, L.-A.H., L.S. Schlesinger, and B. Kang. 2000. Virulent
strains of 
 
Helicobacter pylori
 
 demonstrate delayed phagocytosis
and stimulate homotypic phagosome fusion in macrophages.
 
J. Exp. Med.
 
 191:115–127.
7. Segal, E.D., C. Lange, L.S. Tompkins, and S. Falkow. 1997.
Induction of host signal transduction pathways by 
 
Helicobacter
pylori
 
. 
 
Proc. Natl. Acad. Sci. USA.
 
 94:7595–7599.
8. Censini, S., C. Lange, Z. Xiang, J.E. Crabtree, P. Ghiara, M.
Borodovsky, R. Rappuoli, and A. Covacci. 1996. 
 
cag
 
, a
pathogenicity island of 
 
Helicobacter pylori
 
, encodes type I-spe-
cific and disease-associated virulence factors. 
 
Proc. Natl. Acad.
Sci. USA.
 
 93:14648–14653.
9. Evans, D.J., Jr., D.G. Evans, H.C. Lampert, and H. Nakano.
1995. Identification of four new prokaryotic bacterioferritins,
from 
 
Helicobacter pylori
 
,
 
 Anabaena variabilis
 
, 
 
Bacillus subtilis
 
, and
 
Treponema pallidum
 
, by analysis of gene sequences. 
 
Gene.
 
 153:
123–127.
 
10. Krishnamurthy, P., M. Parlow, N.B. Vakil, H.L. Mobley, M.
Levy, S.H. Phadnis, and B.E. Dunn. 1998. 
 
Helicobacter pylori
 
containing only cytoplasmic urease is susceptible to acid. 
 
In-
fect. Immun.
 
 66:5060–5066.
11. Lee, A. 1998. Animal models for host-pathogen interaction
studies. 
 
Brit. Med. Bull.
 
 54:163–173.
12. Tummuru, M.K.R., S.A. Sharma, and M.J. Blaser. 1995.
 
Helicobacter pylori
 
 picB, a homologue of the 
 
Bordetella pertussis
 
toxin secretion protein, is required for induction of IL-8 in
gastric epithelial cells. 
 
Mol. Microbiol.
 
 18:867–876.
13. DeLeo, F.R., L.-A.H. Allen, M. Apicella, and W.M. Nau-
seef. 1999. NADPH oxidase activation and assembly during
phagocytosis. 
 
J. Immunol.
 
 163:6732–6740.
14. Rautelin, H., G. Blomberg, G. Jarnerot, and D. Danielsson.
1994. Nonopsonic activation of neutrophils and cytotoxin
production by 
 
Helicobacter pylori
 
: ulcerogenic markers. 
 
Scand.
J. Gastroenterol.
 
 29:128–132.
15. Rautelin, H., B. Blomberg, H. Fredlund, G. Jarnerot, and D.
Danielsson. 1993. Incidence of 
 
Helicobacter pylori
 
 strains acti-
vating neutrophils in patients with peptic ulcer disease. 
 
Gut.
 
34:599–603.
16. Makristathis, A., E. Rokita, A. Labigne, B. Willinger, M.L.
Rotter, and A.M. Hirschl. 1998. Highly significant role of
 
Helicobacter pylori
 
 urease in phagocytosis and production of re-
active oxygen metabolites in human granulocytes. 
 
J. Infect.
Dis.
 
 177:803–806.
17. Moran, A.P. 1999. 
 
Helicobacter pylori
 
 lipopolysaccharide-medi-
ated gastric and extragastric pathology. 
 
J. Physiol. Pharmacol.
 
50:787–805.
18. Cunningham, M.D., C. Seachord, K. Ratcliffe, B. Bain-
bridge, A. Aruffo, and R.P. Darveau. 1996. 
 
Helicobacter pylori
 
and 
 
Porphyromonas gingivalis 
 
lipopolysaccharides are poorly
transferred to recombinant soluble CD14. 
 
Infect. Immun.
 
 64:
3601–3608.
19. Andersen, L.P., J. Blom, and H. Nielsen. 1993. Survival and
ultrastructural changes of 
 
Helicobacter pylori
 
 after phagocytosis
by human polymorphonuclear phagocytes and monocytes.
 
APMIS.
 
 101:61–72.
20. Rautelin, H., C.H. von Bonsdorff, B. Blomberg, and D.
Danielsson. 1994. Ultrastructural study of two patterns in the
interaction of 
 
Helicobacter pylori
 
 with neutrophils. 
 
J. Clin.
Pathol.
 
 47:667–669.
21. Rokita, E., A. Makristathis, E. Presterl, M.L. Rotter, and
A.M. Hirschl. 1998. 
 
Helicobacter pylori
 
 urease significantly re-
duces opsonization by human complement. 
 
J. Infect. Dis.
 
178:1521–1525.
22. Allen, L.-A.H., and A. Aderem. 1995. A role for MARCKS,
the alpha isozyme of protein kinase C and myosin I in zymo-
san phagocytosis by macrophages. 
 
J. Exp. Med.
 
 182:829–840.
23. Nixon, J.B., and L.C. McPhail. 2000. Protein kinase C
(PKC) isoforms translocate to Triton-insoluble fractions in
stimulated human neutrophils: correlation of conventional
PKC with activation of NADPH oxidase. 
 
J. Immunol.
 
 163:
4574–4582.